|
|
|
|
pmid:
|
Courtois A et al. |
Evidence for a multidrug resistance-associated protein 1 (MRP1)-related transport system in cultured rat liver biliary epithelial cells. |
1999 |
Life Sci. |
pmid:10075109
|
Courtois A et al. |
Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells. |
1999 |
Cancer Lett. |
pmid:10408915
|
Stratmann A et al. |
Intermediates of rifamycin polyketide synthase produced by an Amycolatopsis mediterranei mutant with inactivated rifF gene. |
1999 |
Microbiology (Reading, Engl.) |
pmid:10627035
|
Doi-Katayama Y et al. |
Thioesterases and the premature termination of polyketide chain elongation in rifamycin B biosynthesis by Amycolatopsis mediterranei S699. |
2000 |
J. Antibiot. |
pmid:10908112
|
Floss HG |
Antibiotic biosynthesis: from natural to unnatural compounds. |
2001 |
J. Ind. Microbiol. Biotechnol. |
pmid:11780790
|
Stratmann A et al. |
New insights into rifamycin B biosynthesis: isolation of proansamycin B and 34a-deoxy-rifamycin W as early macrocyclic intermediates indicating two separated biosynthetic pathways. |
2002 |
J. Antibiot. |
pmid:12061548
|
Rasalkar AA et al. |
Solid state cultivation of Curvularia lunata for transformation of rifamycin B to S. |
2002 |
Indian J. Exp. Biol. |
pmid:12597025
|
Xu J et al. |
Isolation and characterization of 27-O-demethylrifamycin SV methyltransferase provides new insights into the post-PKS modification steps during the biosynthesis of the antitubercular drug rifamycin B by Amycolatopsis mediterranei S699. |
2003 |
Arch. Biochem. Biophys. |
pmid:12623077
|
Jin ZH et al. |
Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening. |
2002 |
J. Gen. Appl. Microbiol. |
pmid:12682871
|
MARGALITH P and PAGANI H |
Rifomycin. XIV. Production of rifomycin B. |
1961 |
Appl Microbiol |
pmid:13766661
|
GIUNCHI G |
The rifamycins. |
1963 |
Antibiot Chemother |
pmid:13948282
|
KLUEPFEL D et al. |
METABOLISM OF BARBITAL BY STREPTOMYCES MEDITERRANEI. |
1965 |
Appl Microbiol |
pmid:14339268
|
El-Enshasy HA et al. |
Improvement of rifemycins production by Amycolatopsis mediterranei in batch and fed-batch cultures. |
2003 |
Acta Microbiol. Pol. |
pmid:14743983
|
Bapat PM and Wangikar PP |
Optimization of rifamycin B fermentation in shake flasks via a machine-learning-based approach. |
2004 |
Biotechnol. Bioeng. |
pmid:15052640
|
Vohra RM |
Novel assay for screening rifamycin B-producing mutants. |
1992 |
Appl. Environ. Microbiol. |
pmid:1539986
|
Jin ZH et al. |
Scale-up of rifamycin B fermentation with Amycolatoposis mediterranei. |
2004 |
J. Zhejiang Univ. Sci. |
pmid:15547969
|
Meier RM and Tamm C |
Studies directed towards the biosynthesis of the C7N-unit of rifamycin B: incorporation of [14C(G)]quinic acid and [1,2-13C2]glycerol. |
1992 |
J. Antibiot. |
pmid:1577667
|
Xiong Y et al. |
A homologue of the Mycobacterium tuberculosis PapA5 protein, rif-orf20, is an acetyltransferase involved in the biosynthesis of antitubercular drug rifamycin B by Amycolatopsis mediterranei S699. |
2005 |
Chembiochem |
pmid:15791687
|
Hartung IV et al. |
Stereochemical assignment of intermediates in the rifamycin biosynthetic pathway by precursor-directed biosynthesis. |
2005 |
J. Am. Chem. Soc. |
pmid:16089423
|